0.0000
0.0000
(0.00%)
As of February 12 at 3:00:00 PM EST. Market Open.
Breakdown
TTM
12/31/2022
Operating Expense
--
2,329.2220
Operating Income
--
-2,329.2220
Net Non Operating Interest Income Expense
--
-167.5200
Other Income Expense
--
6,354.1910
Pretax Income
--
3,857.4490
Net Income Common Stockholders
--
3,857.4490
Diluted NI Available to Com Stockholders
--
3,857.4490
Basic EPS
0.05
0.03
Diluted EPS
0.05
0.03
Basic Average Shares
115,987.1370
113,438.2440
Diluted Average Shares
115,987.1370
113,438.2440
Total Expenses
--
2,329.2220
Net Income from Continuing & Discontinued Operation
--
3,857.4490
Normalized Income
--
3,888.1530
Interest Expense
--
167.5200
Net Interest Income
--
-167.5200
EBIT
--
4,024.9690
EBITDA
--
4,049.4050
Reconciled Depreciation
--
24.4360
Net Income from Continuing Operation Net Minority Interest
--
3,857.4490
Total Unusual Items Excluding Goodwill
193.6210
-41.6100
Total Unusual Items
193.6210
-41.6100
Normalized EBITDA
--
4,091.0150
Tax Rate for Calcs
--
0.0003
Tax Effect of Unusual Items
--
-10.9060
12/31/2022 - 1/13/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
RGBPP Regen BioPharma, Inc.
0.0651
0.00%
XRTX XORTX Therapeutics Inc.
0.9294
-1.13%
SNSE Sensei Biotherapeutics, Inc.
0.4859
+3.69%
BNTC Benitec Biopharma Inc.
10.01
-1.86%
OABI OmniAb, Inc.
3.6250
+1.54%
PSTV Plus Therapeutics, Inc.
1.2150
+8.48%
CELC Celcuity Inc.
12.59
+1.45%
LENZ LENZ Therapeutics, Inc.
24.80
-0.16%
LVTX LAVA Therapeutics N.V.
0.9050
-3.72%
PVLA Palvella Therapeutics, Inc.
18.47
+9.43%